Ultragenyx Pharmaceutical Inc. buy Piper Sandler
Start price
13.01.25
/
50%
€41.20
Target price
13.01.26
€137.24
Performance (%)
-50.00%
End price
14.01.26
€20.60
Summary
This prediction ended on 14.01.26 with a price of €20.60. Massive losses of -50.00% were the result for the BUY prediction by Piper_Sandler. Piper_Sandler has a follow-up prediction for Ultragenyx Pharmaceutical Inc. where he still thinks Ultragenyx Pharmaceutical Inc. is a Buy. Piper_Sandler has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Ultragenyx Pharmaceutical Inc. | 2.970% | 2.970% | -52.074% |
| iShares Core DAX® | -0.197% | -1.724% | 12.342% |
| iShares Nasdaq 100 | -3.612% | -3.768% | 0.437% |
| iShares Nikkei 225® | 1.176% | 2.165% | 19.971% |
| iShares S&P 500 | -0.825% | -1.916% | 0.099% |
Comments by Piper_Sandler for this prediction
In the thread Ultragenyx Pharmaceutical Inc. diskutieren
Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) had its price target raised by analysts at Piper Sandler from $135.00 to $140.00. They now have an "overweight" rating on the stock.
Ratings data for RARE provided by MarketBeat
In the thread Trading Ultragenyx Pharmaceutical Inc.
Die von Piper_Sandler gewählte maximale Laufzeit wurde überschritten
Current prediction by Piper_Sandler for Ultragenyx Pharmaceutical Inc.
Ultragenyx Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€35.20
17.03.25
17.03.25
€105.64
17.03.26
17.03.26
-42.61%
08:38
08:38
Stopped prediction by Piper_Sandler for Ultragenyx Pharmaceutical Inc.
Ultragenyx Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€30.80
25.10.23
25.10.23
€122.98
25.10.24
25.10.24
61.04%
26.10.24
26.10.24